Navigation Links
Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial

of Grade 3/4 diarrhoea) with secondary safety and efficacy endpoints such as disease control, progression free survival and overall survival.

The major findings from the preliminary analysis of trial data are as follows. The two arms of the study were very well balanced for known prognostic factors. Preliminary data regarding toxicity indicates no major differences between the two arms, with an overall impression that HyCAMP(TM) was associated with less cumulative toxicity because the HyCAMP(TM) arm received significantly more doses. The overall incidence of grade 3/4 diarrhoea was lower in this study (14%) than anticipated at the commencement of the trial, presumably reflecting improved medical management today of this side effect in patients, and thereby impeding any meaningful analysis of this endpoint. Patients on HyCAMP(TM) received a median of 6 cycles of therapy, compared to 2 for irinotecan alone (p=0.005). Median progression free survival for HyCAMP(TM) patients was 5.2 months, compared to 2.4 months for the irinotecan arm (p=0.014). Preliminary data indicates the proportion of patients exhibiting disease control (complete responses, partial responses or stable disease) in the HyCAMP(TM) arm was at least 40 % greater than that observed in the irinotecan arm.

Analysis of the trial data is ongoing and full results will be presented when available. This is expected by the end of May. However, from the data analysed to date, HyCAMP(TM) is able to deliver more cycles of therapy and this has translated into an improved disease control rate, and a statistically significant improvement in progression free survival. "The findings have far exceeded our expectations in that we did not expect to achieve a statistically significant improvement in efficacy from such a small number of patients" commented principal investigator Associate Professor Peter Gibbs. Alchemia CEO Dr Ramsdale said "we will be moving as quickly as possible to discuss our plans for fut
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:5/18/2013)... 18, 2013 Although colonoscopy exams prevent many ... most sensitive method for detecting colorectal cancers 2 , ... cases 3 . EndoChoice ® Inc. today unveiled ... improves the accuracy of this procedure and greatly reduces ... be discussing these clinical trial results and featuring the ...
(Date:5/17/2013)... 17, 2013  Lakeland Industries, Inc. (NASDAQ: ... for industry, healthcare and to first responders on the ... results for the fiscal 2013 fourth quarter and year ... at stock market close and will conduct a conference ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced the ... and 130um sorting chip.  Sony will also be exhibiting its ... SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 ... 2013, which will be held at the San ... California , from May 20 - 22.  ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Sony Delivers New Technology for Science to CYTO 2013 2
... N.J., April 26, 2011 Protect Pharmaceutical Corporation (OTCBB: ... current Chief Operating Officer Ramesha Sesha as its Chief ... Mr. Sesha joined Protect as the Chief Operating Officer ... Acquisition Agreement with Nectid Inc where he was the ...
... DUBLIN, April 26, 2011 Amarin Corporation plc (Nasdaq: ... on cardiovascular disease, today announced that John Thero, Amarin,s President, ... to be held at the InterContinental Hotel in Boston. The ... 2011. A live Webcast of the presentation will be available ...
Cached Medicine Technology:Protect Pharmaceutical Corporation Appoints Chief Executive Officer and Chief Financial Officer 2Amarin to Present at the Deutsche Bank 26th Annual Healthcare Conference 2
(Date:5/20/2013)... Townsend Security, a leading authority in ... Alliance Key Manager hardware security module (HSM) will ... for TrueCrypt for Windows . Enterprises can now ... TrueCrypt for data protection. , “Townsend Security is ... for TrueCrypt encryption. Today's announcement reflects our strong ...
(Date:5/19/2013)... Alonso Krangle LLP, an experienced plaintiffs’ law ... woman in a Paternity Petition against Herschel Walker, ... According to an April 23rd filing in New York ... paternity, order of support and further relief as may be ... (Docket No. P-18821-13) , Herschel Walker, is a former ...
(Date:5/19/2013)... May 20, 2013 Due to the ... online advertising, MileageAds.com has decided to invite bloggers and ... their ad network. , Businesses in the Mesothelioma ... with online marketing, specifically with ad networks. , ... and legal services and are unsure where to turn. ...
(Date:5/19/2013)... for nearly half of all hospital admissions, highlighting a ... costs, according to a new report from the RAND ... increased by 17 percent over seven years, accounting for ... and 2009. Hospital inpatient care is a key ... of the nation,s health care expenses. , "This report ...
(Date:5/19/2013)... Cheap Concert Tickets announces that Jimmy ... October will go on sale to the public Monday morning, ... of 2013, this legendary artist will be visiting prime venues ... Five O’clock Somewhere” they instantly remember the good old ... heads. Fortunately, fans can take a trip down memory lane ...
Breaking Medicine News(10 mins):Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 2Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 3Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 2Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 3Health News:Mileageads Ad Network Now Invites Bloggers and Business Owners in Mesothelioma Sector to Advertise on Their Ad Network 2Health News:ER docs are key to reducing health care costs 2Health News:ER docs are key to reducing health care costs 3Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 2Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 3
... be banned by the Government in bars and restaurants, ... by passive smoking. Children suffer from ailments like asthma// ... belonging to the University College London compiled this report ... ,Smokers will be encouraged to quit as a ...
... disease is raised due to smoking, according to a research. ... smoking, which will affect tasks // like driving and reading ... from end stage macular degeneration were studied along with the ... also found that it was the amount smoked rather than ...
... popular movie ‘Stuart Little’ may no longer be a ... from experiments// that it is technically possible to genetically ... ,It has now been found that human ... can be made functional inside another experimental animal such ...
... December 12 issue of Archives of Internal Medicine says that ... developing ovarian cancer by 46 percent. // ... women between the ages of 40 and 76 during 1987 ... epithelial ovarian cancer during this time. When the study started ...
... revealed that wild thrashing during sleep accompanied by cries ... Claudia Trenkwalder said that disruptions in the rapid eye ... to approaching Parkinson's disease, according to the German journal ... and disconnected from motor controls during the R.E.M. sleep ...
... to get more detailed images of the human body as ... also serves to reduce the number of tests which a ... to undergo a series of stress tests and uncomfortable angiograms ... advances in the technology are bringing about a dramatic rise ...
Cached Medicine News:Health News:Mice With Human Thought Processes Could Be Developed In The Future 2
... table that performs as well as your ... use in major surgical suites where control ... B 810 brings better patient outcomes within ... articulation for maximum patient positioning and allows ...
Clearview Chlamydia is a rapid, easy-to-use test for the detection of Chlamydia trachomatis from female endocervical swab specimens....
10-mm (0.4-in) diameter cups have multi-color lead wires and 2-mm (0.08-in) holes for easy paste/collodion application. Available in a variety of lengths to suit many different needs....
... these head cap systems are packaged to ... Each Electro-Cap System features pure tin electrodes ... When you place your order, please specify ... head cap system and whether you want ...
Medicine Products: